Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212): Complete Statistical AnalysisIndependent statistical analysis of Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Multiple Doses of Saxagliptin (BMS-477118): Complete Statistical AnalysisIndependent statistical analysis of Study of Multiple Doses of Saxagliptin (BMS-477118): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00950599).
- Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis: Complete Statistical AnalysisIndependent statistical analysis of Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Nasal Insulin to Fight Forgetfulness – Device Study: Complete Statistical AnalysisIndependent statistical analysis of Study of Nasal Insulin to Fight Forgetfulness - Device Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03857321).
- Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139): Complete Statistical AnalysisIndependent statistical analysis of Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate…
- Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of NKTR 255 in Combination With Cetuximab in Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of NKTR 255 in Combination With Cetuximab in Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma: Complete Statistical AnalysisIndependent statistical analysis of Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment: Complete Statistical AnalysisIndependent statistical analysis of Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of OMNI Surgical System and iStent for Eyes With OAG (Trident): Complete Statistical AnalysisIndependent statistical analysis of Study of OMNI Surgical System and iStent for Eyes With OAG (Trident): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Oral ALXN1840 at 2 Dose Strengths in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of Oral ALXN1840 at 2 Dose Strengths in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis: Complete Statistical AnalysisIndependent statistical analysis of Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion: Complete Statistical AnalysisIndependent statistical analysis of Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor: Complete Statistical AnalysisIndependent statistical analysis of Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.: Complete Statistical AnalysisIndependent statistical analysis of Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of PEG-Intron for Plexiform Neurofibromas: Complete Statistical AnalysisIndependent statistical analysis of Study of PEG-Intron for Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00396019).
- Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355): primary endpoint results, effect estimate…
- Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177): primary endpoint results, effect estimate…
- Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689): primary endpoint results, effect estimate…
- Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02998268).
- Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been…
- Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies: Complete Statistical AnalysisIndependent statistical analysis of Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies: primary endpoint results, effect estimate with confidence…
- STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT: Complete Statistical AnalysisIndependent statistical analysis of STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia: Complete Statistical AnalysisIndependent statistical analysis of Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury: Complete Statistical AnalysisIndependent statistical analysis of Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury: primary endpoint results, effect estimate with confidence interval,…
- Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant: Complete Statistical AnalysisIndependent statistical analysis of Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment: Complete Statistical AnalysisIndependent statistical analysis of Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Prasugrel in Korean Healthy Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Study of Prasugrel in Korean Healthy Male Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01591317).
- Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD: Complete Statistical AnalysisIndependent statistical analysis of Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity: Complete Statistical AnalysisIndependent statistical analysis of Study of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition Insecurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment: Complete Statistical AnalysisIndependent statistical analysis of Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer: primary…
- Study of Propranolol as Anti-Adhesive Therapy in Sickle Cell Disease (SCD): Complete Statistical AnalysisIndependent statistical analysis of Study of Propranolol as Anti-Adhesive Therapy in Sickle Cell Disease (SCD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Quadrivalent Influenza Vaccine Among Children: Complete Statistical AnalysisIndependent statistical analysis of Study of Quadrivalent Influenza Vaccine Among Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01240746).
- Study of Ramucirumab in Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Ramucirumab in Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00721162).
- Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS): Complete Statistical AnalysisIndependent statistical analysis of Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…